Bempegaldesleukin (<scp>BEMPEG</scp>; <scp>NKTR</scp>‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcomaMarlene Hennessy, Nancy Gordon, Murali K. Ravoori et al.|International Journal of Cancer|2020Cited by 20
Abstract 3210: A potential immunotherapeutic approach for the treatment of osteosarcomaMarlene Hennessy, Nancy Gordon, Souri Felix et al.|Cancer Research|2019Cited by 0
Abstract 3210: A potential immunotherapeutic approach for the treatment of osteosarcomaMarlene Hennessy, Nancy P. Gordon, Willem W. Overwijk et al.|Immunology|2019Cited by 0